CDKL3 and cancer: In the TCGA cohort, CDKL3 expression was negatively correlated with the activity of step 4 of the cancer immunity cycles, i.e. immune cell trafficking to the tumor (Supplementary Figure 2A), which was further validated in the GSE47404 cohort (Supplementary Figure 2B).